346 related articles for article (PubMed ID: 20147868)
1. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
[TBL] [Abstract][Full Text] [Related]
2. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
[TBL] [Abstract][Full Text] [Related]
3. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
4. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
[TBL] [Abstract][Full Text] [Related]
5. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Klein M; Koedel U; Pfister HW; Kastenbauer S
Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
Yeung AH; Tinling SP; Brodie HA
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
[TBL] [Abstract][Full Text] [Related]
7. Experimental otoacoustic emission and auditory brainstem response changes by stellate ganglion blockage in rat.
Firat Y; Kizilay A; Ozturan O; Ekici N
Am J Otolaryngol; 2008; 29(5):339-45. PubMed ID: 18722891
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of the inner ear.
Maini S; Lisnichuk H; Eastwood H; Pinder D; James D; Richardson RT; Chang A; Connolly T; Sly D; Kel G; O'Leary SJ
Audiol Neurootol; 2009; 14(6):402-10. PubMed ID: 19923810
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
Plaza G; Herráiz C
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
[TBL] [Abstract][Full Text] [Related]
13. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
[TBL] [Abstract][Full Text] [Related]
14. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
15. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase.
Ge NN; Brodie HA; Tinling SP
Otol Neurotol; 2008 Dec; 29(8):1061-7. PubMed ID: 18849884
[TBL] [Abstract][Full Text] [Related]
16. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis.
Dallan I; De Vito A; Fattori B; Casani AP; Panicucci E; Berrettini S; Marchetti M; Nacci A
Otol Neurotol; 2010 Jan; 31(1):25-30. PubMed ID: 19940792
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intratympanic methylprednisolone acetate in treatment of drill-induced sensorineural hearing loss in guinea pigs.
El-Hennawi DM; El-Deen MH; Abou-Halawa AS; Nadeem HS; Ahmed MR
J Laryngol Otol; 2005 Jan; 119(1):2-7. PubMed ID: 15807953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
